This prospective study included a total of 121 prostate cancer patients that were defined to have low risk (LR), intermediate risk (IR), high risk (HR) or metastatic (M1) disease, according to Gleason score, TNM stage and serum PSA levels (Table 1) [29]. Here, KLK3 is linked to prostate cancer.